Amphastar Pharma(AMPH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Amphastar Pharma

11570 SIXTH STREET
RANCHO CUCAMONGA CA 91730 USA
P: 909-980-9484
http://www.amphastar.com

Profile

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Key Executives

NameTitle
Information not available.

More from The Globe

At Telus, will the new boss deliver a new dividend policy?
Victor Dodig speaks at the Intersect 2025 conference on June 9, 2025 in Toronto.
The highest-yielding stocks on the TSX, plus risk data
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Friday, Nov. 11, 2022.
Two top TSX gainers this year that insiders love (and one big loser)
Ted Dixon
number cruncher
Seven airline stocks that could take flight as oil prices fall
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Gibson Energy Inc.
Monica Rizk
Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in downtown Toronto is photographed on Nov. 11, 2022.
Friday’s analyst upgrades and downgrades
Rock bolting on a scissor lift at Wesdome's Kiena Mine in Val d'Or, Quèbec.
Will a new pipeline reinvigorate Canadian energy stocks?
Pumpjacks pump crude oil near Halkirk, Alta., on June 20, 2007. THE CANADIAN PRESS/Larry MacDougal

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.